Return On Equity of Carisma Therapeutics Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Carisma Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Carisma Therapeutics Inc. Return On Equity for the quarter ending 30 Sep 2025 was -29%, a 97% increase year-over-year.
  • Carisma Therapeutics Inc. annual Return On Equity for 2024 was 871%.
  • Carisma Therapeutics Inc. annual Return On Equity for 2023 was -154%, a 396% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Carisma Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -29% +928% +97% 01 Jul 2025 30 Sep 2025
Q2 2025 162% +507% 01 Apr 2025 30 Jun 2025
Q1 2025 270% +485% 01 Jan 2025 31 Mar 2025
Q4 2024 871% +1025% 01 Oct 2024 31 Dec 2024
Q3 2024 -957% -371% -63% 01 Jul 2024 30 Sep 2024
Q2 2024 -345% -619% -226% 01 Apr 2024 30 Jun 2024
Q1 2024 -216% -319% -311% 01 Jan 2024 31 Mar 2024
Q4 2023 -154% -206% -396% 01 Oct 2023 31 Dec 2023
Q3 2023 -586% -621% -1787% 01 Jul 2023 30 Sep 2023
Q2 2023 274% 01 Apr 2023 30 Jun 2023
Q1 2023 103% 01 Jan 2023 31 Mar 2023
Q4 2022 52% 01 Oct 2022 31 Dec 2022
Q3 2022 35% 01 Jul 2022 30 Sep 2022

Carisma Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 871% +1025% 01 Jan 2024 31 Dec 2024
2023 -154% -206% -396% 01 Jan 2023 31 Dec 2023
2022 52% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.